Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome

被引:37
作者
de Souza, A. W. S.
Silva, N. P.
de Carvalho, J. F.
D'Almeida, V.
Noguti, M. A. E.
Sato, E. I.
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, Div Rheumatol, BR-04023900 Sao Paulo, Brazil
[2] Univ Sao Paulo, Div Rheumatol, Sao Paulo, Brazil
关键词
anti-phospholipid syndromes; atherosclerosis; endothelin-1; homocysteine; lipoprotein lipase; risk factors;
D O I
10.1177/0961203307081847
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to evaluate traditional risk factors for coronary artery disease (CAD), homocysteine, anti-oxidized low-density lipoprotein (anti-oxLDL), anti-lipoprotein lipase (anti-LPL) and endothelin-1 (ET-1) in patients with primary anti-phospholipid syndrome (APS), furthermore verify possible association among these variables and arterial thrombosis. Thirty-eight women with primary APS and 30 age-and-sex-matched controls were evaluated. Patients presented higher-LDL and triglycerides levels and lower-HDL levels than controls. Anti-LPL antibodies were not detected in both groups. The mean number of risk factors was higher in patients than in controls (P = 0.030). Anti-oxLDL antibodies, homocysteine and ET-1 mean levels were similar between Groups, but abnormal homocysteine levels were found only among primary APS patients (P = 0.031). Hypertension and the presence of at least one risk factor for CAD were more prevalent in patients with arterial involvement than those without. Homocysteine levels and mean number of risk factors for CAD were significantly higher in patients with arterial thrombosis than controls. In a multivariate analysis hypertension was the only independently associated with arterial thrombosis (OR 14.8, 95% Cl = 2.1-100.0, P = 0.006). This study showed that in primary APS patients other risk factors besides anti-phospholipid antibodies contribute for the occurrence of arterial events and the most important factor was hypertension.
引用
收藏
页码:782 / 787
页数:6
相关论文
共 33 条
  • [1] Amengual O, 1997, BRIT J RHEUMATOL, V36, P964
  • [2] Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data
    Ames, PRJ
    Margarita, A
    Sokoll, KB
    Weston, M
    Brancaccio, V
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 315 - 317
  • [3] Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies
    Ames, PRJ
    Margarita, A
    Alves, JD
    Tommasino, C
    Iannaccone, L
    Brancaccio, V
    [J]. LUPUS, 2002, 11 (04) : 208 - 214
  • [4] Atsumi T, 1998, ARTHRITIS RHEUM, V41, P800, DOI 10.1002/1529-0131(199805)41:5<800::AID-ART5>3.0.CO
  • [5] 2-J
  • [6] Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic events
    Avivi, I
    Lanir, N
    Hoffman, R
    Brenner, B
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2002, 13 (02) : 169 - 172
  • [7] Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome:: preliminary data
    Barón, MA
    Khamashta, MA
    Hughes, GRV
    D'Cruz, DP
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) : 144 - 146
  • [8] Lipoprotein (a) and apolipoprotein (a) in primary antiphospholipid syndrome
    Becarevic, Mirjana
    Singh, Sandra
    Majkic-Singh, Nada
    [J]. CLINICAL BIOCHEMISTRY, 2007, 40 (5-6) : 317 - 320
  • [9] Are antiphospholipid antibodies an independent risk factor for atherosclerosis?
    Bilora, F
    Boccioletti, V
    Girolami, B
    Zanon, E
    Armani, M
    Petrobelli, F
    Girolami, A
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2002, 8 (02) : 103 - 113
  • [10] Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies
    Borba, EF
    Bonfa, E
    [J]. LUPUS, 1997, 6 (06) : 533 - 539